Prof. Dr. HASAN SADİ GÜLEÇ

Yayın Ağı

Makaleler 113

1. The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort study

Leong D. P., Yusuf R., Iqbal R., Avezum Á., Yusufali A., Rosengren A., et al.

The Lancet Global Health , cilt.13, sa.8, 2025 (SCI-Expanded)

2. Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study

Avezum Á., Mony P. K., Yusuf R., Kazmi K., Szuba A., Lopez-Jaramillo P., et al.

Journal of the American College of Cardiology , cilt.85, sa.5, ss.436-447, 2025 (SCI-Expanded)

3. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Mulder J. W., Tromp T. R., Al-Khnifsawi M., Blom D. J., Chlebus K., Cuchel M., et al.

JAMA Cardiology , cilt.9, sa.4, ss.313-322, 2024 (SCI-Expanded)

4. Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Turkiye Cohort

Oğuz A., KILIÇKAP M., GÜLEÇ H. S., Altuntaş Y., Karşıdağ K., Temizhan A., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.27, sa.8, ss.453-461, 2023 (SCI-Expanded)

5. Global Variations in Heart Failure Etiology, Management, and Outcomes.

Joseph P., Roy A., Lonn E., Störk S., Floras J., Mielniczuk L., et al.

JAMA , cilt.329, sa.19, ss.1650-1661, 2023 (SCI-Expanded, Scopus)

6. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.

YILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.

Hepatology forum , cilt.4, sa.Suppl 1, ss.1-32, 2023 (ESCI, TRDizin)

7. **Comparison of frequency of silent cerebral infarction as assessed by serum neuron specific enolase in patients with non-valvular atrial fibrillation: Warfarin versus direct oral anticoagulant.**

Goksuluk H., ÖZYÜNCÜ N., Duzen I. V., Vurgun V. K., TAN KÜRKLÜ T. S., Gulec S.

Acta cardiologica , cilt.78, sa.3, ss.320-326, 2023 (SCI-Expanded, Scopus)

8. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study.

Lopez-Jaramillo P., Gomez-Arbelaez D., Martinez-Bello D., Abat M. E. M., Alhabib K. F., Avezum Á., et al.

The Lancet. Healthy longevity , cilt.4, 2023 (ESCI, Scopus)

9. Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.

Kızılırmak P., Öngen Z., Güleç S., Kayıkçıoğlu M., Kılıçkap M., Abacı A., et al.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.50, ss.554-560, 2022 (ESCI, Scopus, TRDizin)

10. The role of HDL cholesterol as a measure of 10-year cardiovascular risk should be re-evaluated

Gulec S., EROL Ç.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.29, ss.2132-2134, 2022 (SCI-Expanded)

11. 'Corrigendum to "Association of bedtime with mortality and major cardiovascular events: an analysis of 112,198 individuals from 21 countries in the PURE study" [Sleep Medicine 80 (2021) 265-272]'.

Güleç H. S.

SLEEP MEDICINE , cilt.2022, sa.92, ss.108, 2022 (SCI-Expanded, Scopus)

12. Psychosocial Risk Factors and Cardiovascular Disease and Death in a Population-Based Cohort From 21 Low-, Middle-, and High-Income Countries

Santosa A., Rosengren A., Ramasundarahettige C., Rangarajan S., Chifamba J., Lear S. A., et al.

JAMA NETWORK OPEN , cilt.4, sa.12, 2021 (SCI-Expanded, Scopus)

13. Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries.

Mohan D., Mente A., Dehghan M., Rangarajan S., O'Donnell M., Hu W., et al.

JAMA internal medicine , cilt.181, sa.5, ss.631-649, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality

Jenkins D. J. A., Dehghan M., Mente A., Bangdiwala S. I., Rangarajan S., Srichaikul K., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.384, sa.14, ss.1312-1322, 2021 (SCI-Expanded, Scopus)

15. Relationship between silent cerebral infarcts and quality of anticoagulation in patients with prosthetic mitral valves

ÖZYÜNCÜ N., Gulec S., Goksuluk H., ESENBOĞA K., Tutar E.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.3, ss.191-195, 2021 (SCI-Expanded, Scopus, TRDizin)

16. Çıplak Metal Stentler ve İlaç Salınımlı Stentlerin C-Reaktif Protein Düzeyleri Üzerine Etkilerinin Karşılaştırılması

ÖZYÜNCÜ N., GÜLEÇ H. S., ÖZCAN Ö. U., GÖKSÜLÜK H., GEREDE D. M., EROL Ç.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , 2021 (Hakemli Dergi)

17. Risk of cardiovascular events in patients with metabolic syndrome: Results of a population-based prospective cohort study (PURE Turkey)

OĞUZ A., KILIÇKAP M., GÜLEÇ H. S., Altuntas Y., Karsidag K., Temizhan A., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.24, sa.3, ss.192-200, 2020 (SCI-Expanded, Scopus, TRDizin)

18. New-onset Atrial Fibrillation: An Independent Predictor of in-hospital Mortality in Reduced Ejection Fraction Heart Failure Patients

ÖZYÜNCÜ N., GÜLEÇ H. S.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.2, ss.102-106, 2020 (Hakemli Dergi)

19. Kalp Yetersizliği Hospitalizasyonunda Yeni Atriyal Fibrilasyon Gelişim Riski

ÖZYÜNCÜ N., GÜLEÇ H. S.

MN Kardiyoloji , cilt.27, sa.1, ss.35-39, 2020 (Hakemli Dergi)

20. Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries

Chow C. K., Nguyen T. N., Marschner S., Diaz R., Rahman O., Avezum A., et al.

BMJ GLOBAL HEALTH , cilt.5, sa.11, 2020 (SCI-Expanded, SSCI, Scopus)

21. Relation of Acute Decompensated Heart Failure to Silent Cerebral Infarcts in Patients With Reduced Left Ventricular Ejection Fraction

Özyüncü N., Güleç H. S., Tulunay Kaya C., Goksuluk H., Tan T. S., Vurgun V. K., et al.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.123, sa.11, ss.1835-1839, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study

Rosengren A., Smyth A., Rangarajan S., Ramasundarahettige C., Bangdiwala S., AlHabib K. F., et al.

LANCET GLOBAL HEALTH , cilt.7, sa.6, 2019 (SCI-Expanded, SSCI, Scopus)

23. Çıplak ve İlaç Salınımlı Stentlerin Perkütan Koroner GirişimSonrası C-Reaktif Protein Üzerine Etkilerinin Karşılaştırılması

DÜZEN İ. V., GÜLEÇ H. S., ÖZYÜNCÜ N., Göksülük H., EROL Ç.

MN Kardioloji , cilt.26, sa.1, ss.1-6, 2019 (Hakemli Dergi)

24. Risk and dyslipidemia

GÜLEÇ H. S.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.46, sa.7, ss.575-576, 2018 (ESCI)

25. Comparison of Frequency of Silent Cerebral Infarction After Coronary Angiography and Stenting With Transradial Versus Transfemoral Approaches

Goksuluk H., GÜLEÇ H. S., ÖZYÜNCÜ N., Kurklu S. T., Vurgun V. K., CANDEMİR B., et al.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.122, sa.4, ss.548-553, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study

Mente A., O'Donnell M., Rangarajan S., McQueen M., Dagenais G., Wielgosz A., et al.

LANCET , cilt.392, sa.10146, ss.496-506, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world

Joseph P., Yusuf S., Lee S. F., Ibrahim Q., Teo K., Rangarajan S., et al.

HEART , cilt.104, sa.7, ss.581-587, 2018 (SCI-Expanded, Scopus)

28. Non-valvüler Atriyal Fibrilasyon Hastalarında CHA2DS2VASc ve ATRİA Risk Skorlarının Değerlendirilmesi

GÖKSÜLÜK H., GÜLEÇ H. S., CANDEMİR B., TULUNAY KAYA C., ÖZYÜNCÜ N., VURGUN V. K., et al.

MN Kardiyoloji , cilt.25, sa.1, ss.18-23, 2018 (Hakemli Dergi)

29. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study

Miller V., Mente A., Dehghan M., Rangarajan S., Zhang X., Swaminathan S., et al.

LANCET , cilt.390, sa.10107, ss.2037-2049, 2017 (SCI-Expanded, Scopus)

30. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Dehghan M., Mente A., Zhang X., Swaminathan S., Li W., Mohan V., et al.

LANCET , cilt.390, sa.10107, ss.2050-2062, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study

Mente A., Dehghan M., Rangarajan S., McQueen M., Dagenais G., Wielgosz A., et al.

LANCET DIABETES & ENDOCRINOLOGY , cilt.5, sa.10, ss.774-787, 2017 (SCI-Expanded, Scopus)

32. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Attaei M. W., Khatib R., McKee M., Lear S., Dagenais G., Igumbor E. U., et al.

LANCET PUBLIC HEALTH , cilt.2, sa.9, 2017 (SCI-Expanded, Scopus)

33. Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease

ÖZYÜNCÜ N., GÜLEÇ H. S., ÖZDÖL Ç., CANDEMİR B., ONGUN A., TULUNAY KAYA C., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.17, sa.5, ss.386-391, 2017 (SCI-Expanded, Scopus, TRDizin)

34. Koroner anjiyografi/Elektif perkütan koroner girişim yapılan hastalarda femoral ve radiyal giriş yerine göre sessiz serebral iskeminin karşılaştırılması.

GÖKSÜLÜK H., GÜLEÇ H. S., GEREDE D. M., CANDEMİR B., TULUNAY KAYA C., ÖZTÜRK S., et al.

MN Kardiyoloji , 2017 (Hakemli Dergi)

35. Koroner anjiografi/elektif perkütan koroner girişim yapılan hastalarda femoral ve radyal giriş yerine göre sessiz serebral iskeminin karşılaştırılması

GÖKSÜLÜK H., GÜLEÇ H. S., GEREDE D. M., CANDEMİR B., TULUNAY KAYA C., öztürk s., et al.

MN Kardiyoloji , cilt.24, sa.1, 2017 (Hakemli Dergi)

36. Cost of heart failure management in Turkey: results of a Delphi Panel

Aras D., Aydogdu S., Bozkurt E., ÇAVUŞOĞLU Y., Eren M., EROL Ç., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.16, sa.8, ss.554-562, 2016 (SCI-Expanded, Scopus, TRDizin)

37. Usefulness of Neuron-Specific Enolase to Detect Silent Neuronal Ischernia After Percutaneous Coronary Intervention

Goksuluk H., GÜLEÇ H. S., Ozcan O. U., Gerede M., Vurgun V. K., ÖZYÜNCÜ N., et al.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.117, sa.12, ss.1917-1920, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Assessing global risk factors for non-fatal injuries from road traffic accidents and falls in adults aged 35-70 years in 17 countries: a cross-sectional analysis of the Prospective Urban Rural Epidemiological (PURE) study

Raina P., Sohel N., Oremus M., Shannon H., Mony P., Kumar R., et al.

INJURY PREVENTION , cilt.22, sa.2, ss.92-98, 2016 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

39. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Khatib R., Mckee M., Shannon H., Chow C., Rangarajan S., Teo K., et al.

LANCET , cilt.387, sa.10013, ss.61-69, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST-segment elevation myocardial infarction

GEREDE ULUDAĞ D. M., GÜLEÇ H. S., KILIÇKAP M., TULUNAY KAYA C., Vurgun V. K., Ozcan O. U., et al.

CARDIOVASCULAR JOURNAL OF AFRICA , cilt.26, sa.6, ss.204-209, 2015 (SCI-Expanded, Scopus)

41. Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study

Smyth A., Teo K. K., Rangarajan S., O'Donnell M., Zhang X., Rana P., et al.

LANCET , cilt.386, sa.10007, ss.1945-1954, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period

Baha R. M., ÖZDÖL Ç., GÜLEÇ H. S., EROL Ç.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.43, sa.5, ss.443-449, 2015 (ESCI, Scopus, TRDizin)

43. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study

Leong D. P., Teo K. K., Rangarajan S., Lopez-Jaramillo P., Avezum A., Orlandini A., et al.

LANCET , cilt.386, sa.9990, ss.266-273, 2015 (SCI-Expanded, Scopus)

44. Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome

Ozcan O. U., Ustun E. E., GÜLEÇ H. S., GEREDE ULUDAĞ D. M., Goksuluk H., Vurgun V. K., et al.

CARDIOLOGY JOURNAL , cilt.22, sa.3, ss.323-329, 2015 (SCI-Expanded, Scopus)

45. Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients

Ozcan O. U., Er H. A., GÜLEÇ H. S., Ustun E. E., GEREDE ULUDAĞ D. M., Goksuluk H., et al.

CLINICAL CARDIOLOGY , cilt.38, sa.3, ss.150-156, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Abdominal Obesity Perception in Turkish Population

OĞUZ A., Temizhan A., Altuntas Y., Karsidag K., GÜLEÇ H. S., TELCİ ÇAKLILI Ö.

JOURNAL OF NUTRITION EDUCATION AND BEHAVIOR , cilt.47, sa.2, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Comparison of the Effects of Bare Metal Stents and DrugEluting Stents on C Reactive Protein Levels

ÖZYÜNCÜ N., GÜLEÇ H. S., ÖZCAN Ö. U., GÖKSÜLÜK H., GEREDE D. M., ÇAĞLAR M. N., et al.

Journal of Heart and Cardiology , 2015 (Hakemli Dergi)

48. Valsartan after myocardial infarction

GÜLEÇ H. S.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.14, 2014 (SCI-Expanded, Scopus, TRDizin)

49. The Cost Implications of Off-Pump Versus On-Pump Coronary Artery Bypass Graft Surgery at One Year

Lamy A., Tong W., Devereaux P. J., Gao P., Gafni A., Singh K., et al.

ANNALS OF THORACIC SURGERY , cilt.98, sa.5, ss.1620-1625, 2014 (SCI-Expanded, Scopus)

50. Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

O'Donnell M., Mente A., Rangarajan S., McQueen M. J., Wang X., Liu L., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.371, sa.7, ss.612-623, 2014 (SCI-Expanded, Scopus)

51. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

Yusuf S., Rangarajan S., Teo K., Islam S., Li W., Liu L., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.371, sa.9, ss.818-827, 2014 (SCI-Expanded, Scopus)

52. Association of Urinary Sodium and Potassium Excretion with Blood Pressure

Mente A., O'Donnell M. J., Rangarajan S., McQueen M. J., Poirier P., Wielgosz A., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.371, sa.7, ss.601-611, 2014 (SCI-Expanded, Scopus)

53. Steroid use in kidney transplant recipients presented with acute myocardial infarction

Ozcan O. U., GÜLEÇ H. S., Gursoy E., Celebi Z. K., EROL Ç.

HEART & LUNG , cilt.43, sa.4, ss.289-291, 2014 (SCI-Expanded, Scopus)

54. Misinterpretation of the HAS-BLED bleeding score by end-users

GÜLEÇ H. S.

THROMBOSIS RESEARCH , cilt.134, sa.1, ss.203, 2014 (SCI-Expanded, Scopus)

55. Possible limitations of using the HAS-BLED bleeding score in real life settings

GÜLEÇ H. S.

THROMBOSIS RESEARCH , cilt.133, sa.6, ss.959-960, 2014 (SCI-Expanded, Scopus)

56. Diagnosis and treatment of stage 1 hypertension: Which guidelines should we follow?

GÜLEÇ H. S.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION , cilt.8, sa.5, ss.358-359, 2014 (SCI-Expanded)

57. The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries

Lear S. A., Teo K., Gasevic D., Zhang X., Poirier P. P., Rangarajan S., et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL , cilt.186, sa.4, ss.258-266, 2014 (SCI-Expanded, Scopus)

58. Early diagnosis saves lives: focus on patients with hypertension

GÜLEÇ H. S.

KIDNEY INTERNATIONAL SUPPLEMENTS , cilt.3, sa.4, ss.332-334, 2013 (SCI-Expanded, Scopus)

59. Marked Narrowing of Right Heart Chambers Due to Compression by Giant Hepatic Hydatid Cyst

Ozcan O. U., Er H. A., TURHAN S., GÜLEÇ H. S., Sogut G., KOZLUCA V., et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES , cilt.30, sa.10, 2013 (SCI-Expanded, Scopus)

60. Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries

Corsi D. J., Subramanian S. V., Chow C. K., Mckee M., Chifamba J., Dagenais G., et al.

AMERICAN HEART JOURNAL , cilt.166, sa.4, ss.636-650, 2013 (SCI-Expanded, Scopus)

61. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

Chow C. K., Teo K. K., Rangarajan S., Islam S., Gupta R., Avezum A., et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , cilt.310, sa.9, ss.959-968, 2013 (SCI-Expanded, Scopus)

62. Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries The Prospective Urban Rural Epidemiology (PURE) Study

Teo K., Lear S., Islam S., Mony P., Dehghan M., Li W., et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , cilt.309, sa.15, ss.1613-1621, 2013 (SCI-Expanded, Scopus)

63. Coronary artery ectasia

Ozcan O. U., GÜLEÇ H. S.

Cor et Vasa , cilt.55, sa.3, 2013 (Scopus)

64. Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study

GÖKCE M. İ., GÜLPINAR Ö., Ozturk E., GÜLEÇ H. S., YAMAN M. Ö.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.44, sa.3, ss.683-687, 2012 (SCI-Expanded, Scopus)

65. Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias

Clarke R., Bennett D. A., Parish S., Verhoef P., Dotsch-Klerk M., Lathrop M., et al.

PLOS MEDICINE , cilt.9, sa.2, 2012 (SCI-Expanded, Scopus)

66. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Yusuf S., Islam S., Chow C. K., Rangarajan S., Dagenais G., Diaz R., et al.

LANCET , cilt.378, sa.9798, ss.1231-1243, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. ESC/EAS Guidelines for the management of dyslipidaemias

Reiner Z., Catapano A. L., De Backer G., Graham I., Taskinen M., Wiklund O., et al.

EUROPEAN HEART JOURNAL , cilt.32, sa.14, ss.1769-1818, 2011 (SCI-Expanded, Scopus)

68. Very late drug-eluting stent thrombosis in a patient with an INR of 4.4

CANDEMİR B., GÜLEÇ H. S., Özdemir A. O., KUMBASAR S. D.

Turk Kardiyoloji Dernegi Arsivi , cilt.38, sa.8, ss.561-563, 2010 (SCI-Expanded, Scopus, TRDizin)

69. The relation between endothelial dependent flow mediated dilation of the brachial artery and coronary collateral development - a cross sectional study

Ozdemir A., GÜLEÇ H. S., Uslu N., TULUNAY KAYA C., ÖZDÖL Ç., TURHAN S., et al.

CARDIOVASCULAR ULTRASOUND , 2009 (SCI-Expanded, Scopus)

70. [Global risk and objectives in cardiovascular diseases]. Kalp damar hastaliklarinda global risk ve hedefler.

GÜLEÇ H. S.

Türk Kardiyoloji Derneǧi arşivi : Türk Kardiyoloji Derneǧinin yayin organidir , cilt.37 Suppl 2, ss.1-10, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

71. The JUPITER trial: a new approach in primary prevention JUPITER çalişmasi: Primer korumada yeni bir yaklaşim.

GÜLEÇ H. S.

Türk Kardiyoloji Derneǧi arşivi : Türk Kardiyoloji Derneǧinin yayin organidir , cilt.37 Suppl 4, ss.18-26, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

72. Renin inhibition in hypertension Hipertansiyonda renin inhibisyonu.

GÜLEÇ H. S.

Türk Kardiyoloji Derneǧi arşivi : Türk Kardiyoloji Derneǧinin yayin organidir , cilt.37 Suppl 7, ss.15-22, 2009 (SCI-Expanded)

73. Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development

GÜLEÇ H. S., KARABULUT H. G., Ozdemir A., ÖZDÖL Ç., TURHAN S., Altin T., et al.

ATHEROSCLEROSIS , sa.2, ss.354-359, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. The effect of high-dose aspirin pre-treatment on the incidence of myonecrosis following elective coronary stenting

GÜLEÇ H. S., ÖZDÖL Ç., Vurgun K., Selcuk T., TURHAN S., Duzen V., et al.

ATHEROSCLEROSIS , sa.1, ss.171-176, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group

Tokgoz H., YAMAN M. Ö., GÜLEÇ H. S., Soyupek S., Sahinli S., Anafarta K.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.40, sa.2, ss.373-376, 2008 (SCI-Expanded, Scopus)

76. The effect of cardiac rehabilitation on quality of life, anxiety and depression in patients with congestive heart failure. A randomized controlled trial, short-term results.

Kulcu D., Kurtais Y., SONEL TUR B., GÜLEÇ H. S., Seckin B.

Europa medicophysica , cilt.43, sa.4, ss.489-97, 2007 (Scopus)

77. Aspirin in patients undergoing percutaneous coronary intervention

GÜLEÇ H. S.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.7, ss.9-13, 2007 (SCI-Expanded, Scopus, TRDizin)

78. The story that begins with willow tree

GÜLEÇ H. S.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.7, ss.1, 2007 (SCI-Expanded)

79. Relationship between angiotensin-converting enzyme gene polymorphism and severity of aortic valve calcification

Ertas F. S., Hasan T., Ozdol C., GÜLEÇ H. S., Atmaca Y., Tulunay C., et al.

MAYO CLINIC PROCEEDINGS , sa.8, ss.944-948, 2007 (SCI-Expanded, Scopus)

80. The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vessel development

Altin T., Kilickap M., TUTAR D. E., Turhan S., Atmaca Y., GÜLEÇ H. S., et al.

INTERNATIONAL HEART JOURNAL , sa.4, ss.435-442, 2007 (SCI-Expanded, Scopus)

81. The association between androgen levels and premature coronary artery disease in men

Turhan S., Tulunay C., GÜLEÇ H. S., Ozdol C., Kilickap M., Altin T., et al.

CORONARY ARTERY DISEASE , cilt.18, sa.3, ss.159-162, 2007 (SCI-Expanded, Scopus)

82. Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study)

Ilerigelen B., Ueresin Y., San M., Kueltuesay H., Gueneri S., Serdar O. A., et al.

CURRENT MEDICAL RESEARCH AND OPINION , cilt.23, sa.5, ss.1093-1102, 2007 (SCI-Expanded, Scopus)

83. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention

Ozdol C., GÜLEÇ H. S., Rahimov U., Atmaca Y., Turhan S., Erol Ç.

THROMBOSIS RESEARCH , sa.4, ss.453-459, 2007 (SCI-Expanded, Scopus)

84. Aspirin in patients undergoing percutaneous coronary intervention,Perkütan koroner girişim uygulanan hastalarda aspirin

Gülec S.

Anadolu Kardiyoloji Dergisi , cilt.7, ss.9-13, 2007 (Scopus)

85. ACC 2006 [8]

GÜLEÇ H. S.

Anadolu Kardiyoloji Dergisi , cilt.6, sa.2, ss.203, 2006 (SCI-Expanded)

86. Elevated levels of C-reactive protein are associated with impaired coronary collateral development

GÜLEÇ H. S., Ozdemir A., Maradit-Kremers H., Dincer I., Atmaca Y., Erol Ç.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , sa.6, ss.369-375, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Unrecognized side effect of statin treatment: unilateral blepharoptosis

Ertas F. S., Ertas N. M., GÜLEÇ H. S., Atmaca Y., Tanju S., Sener C., et al.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY , sa.3, ss.222-224, 2006 (SCI-Expanded, Scopus)

88. Editöre mektup

GÜLEÇ H. S., EROL Ç.

Turk Kardiyoloji Dernegi Arsivi , cilt.34, sa.1, ss.71, 2006 (SCI-Expanded)

89. Myonecrosis after elective percutaneous coronary intervention: Effect of clopidogrel-statin interaction

GÜLEÇ H. S., Ozdol C., Rahimov U., ATMACA Y., KUMBASAR S. D., EROL Ç.

Journal of Invasive Cardiology , cilt.17, sa.11, ss.589-593, 2005 (Scopus)

90. Angiographic evaluation of myocardial perfusion in patients with syndrome X

Atmaca Y., Ozdemir A., Ozdol C., Oguz D., GÜLEÇ H. S., KUMBASAR S. D., et al.

AMERICAN JOURNAL OF CARDIOLOGY , sa.6, ss.803-805, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

91. Effect of direct stent implantation on QTc dispersion

Atmaca Y., Ozdol C., Ertas F., Altin T., GÜLEÇ H. S., Oral D.

ANGIOLOGY , sa.2, ss.143-149, 2005 (SCI-Expanded, Scopus)

92. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.

TUTAR D. E., Ozcan M., Kilickap M., GÜLEÇ H. S., Aras O., Pamir G., et al.

Circulation , cilt.108, sa.13, ss.1581-4, 2003 (SCI-Expanded, Scopus)

93. Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia

GÜLEÇ H. S., Atmaca Y., Kilickap M., Akyurek O., Aras O., Oral D.

AMERICAN JOURNAL OF CARDIOLOGY , sa.8, ss.996-999, 2003 (SCI-Expanded, Scopus)

94. Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting

Atmaca Y., Dandachi R., GÜLEÇ H. S., DİNÇER İ., Oral D.

INTERNATIONAL JOURNAL OF CARDIOLOGY , sa.2-3, ss.143-149, 2003 (SCI-Expanded, Scopus)

95. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis

Erdogan M. F., GÜLEÇ H. S., TUTAR D. E., Baskal N., Erdogan G.

THYROID , cilt.13, sa.2, ss.205-209, 2003 (SCI-Expanded, Scopus)

96. Deletion polymorphism of the angiotensin I converting enzyme gene is a potent risk factor for coronary artery ectasia

Gülec S., Aras Ö., Atmaca Y., Akyürek Ö., Hanson N., Sayin T., et al.

HEART , sa.2, ss.213-214, 2003 (SCI-Expanded, Scopus)

97. The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting

Atmaca Y., GÜLEÇ H. S., Ertas F., Pamir G., Oral D.

INTERNATIONAL JOURNAL OF CARDIOLOGY , sa.2-3, ss.151-157, 2003 (SCI-Expanded, Scopus)

98. Akut miyokard infaktüsünde çok damar girişimi

ATMACA Y., ÖZDÖL Ç., ALTIN A. T., TULUNAY KAYA C., GEREDE D. M., DANDACHİ R., et al.

MN Kardiyoloji , 2003 (TRDizin)

99. MTHFR 677C -> T polymorphism and risk of coronary heart disease - A meta-analysis

Klerk M., Verhoef P., Clarke R., Blom H., Kok F., Schouten E.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , cilt.288, sa.16, ss.2023-2031, 2002 (SCI-Expanded, Scopus)

100. Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population

Aras O., Hanson N., Bakanay S., Tsai M., GÜLEÇ H. S.

THROMBOSIS AND HAEMOSTASIS , cilt.87, sa.2, ss.347-349, 2002 (SCI-Expanded, Scopus)

101. Effect of direct stent implantation on minor myocardial injury

Atmaca Y., Ertas F., Gülec S., Dincer I., Oral D.

Journal of Invasive Cardiology , cilt.14, ss.443-446, 2002 (Hakemli Dergi)

102. Exercise-induced myocardial ischemia in patients with coronary artery ectasia without obstructive coronary artery disease

Sayin T., Doven O., Berkalp B., Akyurek O., GÜLEÇ H. S., Oral D.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.78, sa.2, ss.143-149, 2001 (SCI-Expanded, Scopus)

103. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction

GÜLEÇ H. S., Aras O., Akar E., TUTAR D. E., Omurlu K., Avci F., et al.

CLINICAL CARDIOLOGY , cilt.24, sa.4, ss.281-284, 2001 (SCI-Expanded, Scopus)

104. Hyperhomocysteinemia and restenosis

KUMBASAR S. D., DİNÇER İ., Ertas F., GÜLEÇ H. S., Erol Ç., Akyurek O., et al.

JOURNAL OF CARDIOVASCULAR RISK , cilt.8, sa.1, ss.9-13, 2001 (SCI-Expanded)

105. Clinical investigations: Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction

Güleç S., Aras Ö., Akar E., Tutar E., Ömürlü K., Avci F., et al.

Clinical Cardiology , cilt.24, ss.281-284, 2001 (Scopus)

106. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting

Gurlek A., GÜLEÇ H. S., KARABULUT H. G., Bokesoy I., TUTAR D. E., Pamir G., et al.

JOURNAL OF CARDIOVASCULAR RISK , cilt.7, sa.6, ss.403-407, 2000 (SCI-Expanded)

107. Atrial sensing performance of a single-lead VDD pacing system during physical activities

Ertas F., Karaoguz R., Guldal M., KUMBASAR S. D., GÜLEÇ H. S., Oral D.

JOURNAL OF ELECTROCARDIOLOGY , cilt.33, sa.3, ss.253-260, 2000 (SCI-Expanded, Scopus)

108. Left atrial appendage function in patients with different pacing modes

Ertas F., GÜLEÇ H. S., DİNÇER İ., Erol Ç., TUTAR D. E., Guldal M., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.73, sa.2, ss.135-141, 2000 (SCI-Expanded, Scopus)

109. HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction

Erdogan M., GÜLEÇ H. S., TUTAR D. E., Guldal M., Baskal N., Erdogan G.

THYROID , cilt.10, sa.4, ss.369-370, 2000 (SCI-Expanded, Scopus)

110. Bronchial hyperreactivity in patients with mitral stenosis before and after successful percutaneous mitral balloon valvulotomy

GÜLEÇ H. S., Ertas F., Tutar E., Demirel Y., Karaoguz R., Omurlu K., et al.

CHEST , cilt.116, sa.6, ss.1582-1586, 1999 (SCI-Expanded, Scopus)

111. Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale

Tutar E., Kaya A., GÜLEÇ H. S., Ertas F., Erol Ç., Ozdemir Ö., et al.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.83, sa.9, ss.1414-1418, 1999 (SCI-Expanded, Scopus)

112. Value of ST-segment depression during paroxysmal supraventricular tachycardia in the diagnosis of coronary artery disease

GÜLEÇ H. S., Ertab F., Karaoouz R., Guldal M., Alpman A., Oral D.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.83, sa.3, ss.458-461, 1999 (SCI-Expanded, Scopus)

113. Exercise performance in patients with dilated cardiomyopathy: Relationship to resting left ventricular function

GÜLEÇ H. S., Ertas F., TUTAR D. E., Caglar N., Akgun C., Alpman A., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.65, sa.3, ss.247-253, 1998 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. Comparison of the effects of bare metal stents and drug eluting stents on c-reactive protein levels(e-sunu link: https://ktv.kvakademi.org/ktvyeni/etkinlikler/iyacdetay/94/abstract-session-10:-biomarkers-3)

ÖZYÜNCÜ N., GÜLEÇ H. S., Ozcan O. U., GÖKSÜLÜK H., GEREDE D. M., Çağlar N., et al.

Cardiovascular Academy Congress Digital 2020- International Young Academy of Cardiology E-Congress 2020, Türkiye, 16 - 20 Eylül 2020, ss.52, (Tam Metin Bildiri)